Innovating Works

MyB

Desconocido
GreenX3: Innovative and sustainable materials, processes and technologies for a GREENer and circular economy MYBIOTECH GMBH tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 GreenX3 is a multidisciplinary and innovative project designed to use chemical tools to address the current global environmental challenges....
2023-09-01 - 2027-08-31 | Financiado
NABIHEAL: ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING MYBIOTECH GMBH participó en un HORIZON EUROPE: HORIZON-CL4-2022-RESILIENCE-01 Complex wounds impact the quality of life of more than 2% of total population in developed countries being a global health problem with sign...
2022-11-29 - 2026-12-31 | Financiado
POTENTIAL: Platform Optimisation To Enable NanomaTerIAL safety assessment for rapid commercialisation MYBIOTECH GMBH participó en un HORIZON EUROPE: HORIZON-CL4-2022-DIGITAL-EMERGING-01 Advanced Nanomaterials (Ad-NMs) will lead a new industrial revolution and accelerate the transition to greener technologies and better healt...
2022-11-24 - 2026-12-31 | Financiado
TALENTS: Training AlliancE for Novel Microbiome-Modulating TherapieS MYBIOTECH GMBH participó en un HORIZON EUROPE: HORIZON-MSCA-2021-COFUND-01 TALENTS aims to build up an international programme for interdisciplinary and transsectorial training of 15 doctoral candidates (DCs) as nee...
2022-09-02 - 2027-12-31 | Financiado
ETERNAL: Boosting the reduction of the environmental impact of pharmaceutical products throughout their entir... MYBIOTECH GMBH participó en un HORIZON EUROPE: HORIZON-HLTH-2021-IND-07 ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycl...
2022-05-23 - 2026-08-31 | Financiado
Phoenix: Pharmaceutical Open Innovation Test Bed for Enabling Nano pharmaceutical Innovative Products MYBIOTECH GMBH participó en un H2020: H2020-NMBP-TO-IND-2018-2020 Nano-pharmaceuticals have the potential to drive the scientific and technological uplift, offering great clinical and socio-economic benefit...
2020-12-16 - 2025-02-28 | Financiado
CompSafeNano: NanoInformatics Approaches for Safe by Design NanoMaterials MYBIOTECH GMBH participó en un H2020: H2020-MSCA-RISE-2020 The unique properties of nanomaterials (NMs), relative to their bulk form, has seen them used in a rapidly increasing number of commercial a...
2020-10-13 - 2026-08-31 | Financiado
Bio2Brain: Nose to Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases A de... MYBIOTECH GMBH participó en un H2020: H2020-MSCA-ITN-2020 Bio2Brain aims to create a trans-European network of industrially oriented specialists fully trained and experienced, a significant driving...
2020-08-18 - 2024-12-31 | Financiado
NanoCarb: Glyco Nanoparticles for Applications in Advance Nanomedicine MYBIOTECH GMBH participó en un H2020: H2020-MSCA-ITN-2018 The advance of nanomedicine requires the development of novel materials with tailored properties, controlled circulation, optimal targeting...
2018-08-20 - 2023-03-31 | Financiado
iFermenter: iFERMENTER CONVERSION OF FORESTRY SUGAR RESIDUAL STREAMS TO ANTIMICROBIAL PROTEINS BY INTELLIGENT... MYBIOTECH GMBH participó en un H2020: H2020-BBI-JTI-2017 Plant dry matter, so-called lignocellulosic biomass, is the largest renewable biomass feedstock on Earth. Europe has over 14 mill tons of su...
2018-04-24 - 2022-07-31 | Financiado
nTRACK: Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regen... MYBIOTECH GMBH participó en un H2020: H2020-NMBP-2016-2017 Cell therapy offers promising opportunities to approach several diseases for which no effective therapies are currently available. However,...
2017-10-30 - 2022-03-31 | Financiado
NANOSTEM: New nanomaterials for neural stem cells drug delivery MYBIOTECH GMBH participó en un H2020: H2020-MSCA-ITN-2017 Brain conditions such as neurodegenerative diseases, stroke and traumatic injuries are a mayor burden in modern society. Because neural stem...
2017-08-30 - 2022-05-31 | Financiado
npSCOPE: The nanoparticle scope a new integrated instrument for accurate and reproducible physico chemical... MYBIOTECH GMBH participó en un H2020: H2020-NMBP-2016-2017 The npSCOPE project aims at developing a new integrated instrument (the nanoparticle-scope) optimised for providing a complete physico-chemi...
2016-11-09 - 2021-06-30 | Financiado
N2B-patch: Nose to Brain Delivery of Antibodies via the Olfactory Region for the Treatment of Multiple Sclerosi... MYBIOTECH GMBH participó en un H2020: H2020-NMBP-2016-2017 The overall aim of N2B-patch is the development of a new innovative N2B drug delivery technology based on the synthesis of a biomaterial-bas...
2016-11-09 - 2021-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.